On Air Now

Upcoming Shows

Program Schedule »

Tune in to Listen

1440 AM Green Bay, WI

Weather

Current Conditions(Green Bay,WI 54303)

More Weather »
38° Feels Like: 28°
Wind: SSW 21 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Tonight

Rain/Wind 36°

Tomorrow

AM Rain/Snow Showers 46°

Fri Night

Partly Cloudy 27°

Alerts

  • 0 Severe Weather Alerts
  • 0 Cancellations

Pharma company Resverlogix to spin off unit

(Reuters) - Canadian pharmaceutical company Resverlogix Corp, which is exploring a sale, said it would spin off its RVX Therapeutics Inc unit.

Resverlogix shares touched a more than two-year high of C$3.49 in early trading on the Toronto Stock Exchange.

Shareholders will receive one share in the new company for every share held in Resverlogix, the company said.

The spun-off unit will focus on epigenetics, the study of the mechanisms that activate and de-activate genes.

The company, which has a market capitalization of about C$242 million ($237.20 million), said it will continue the clinical development of RVX-208, an experimental drug for treating hardening of the arteries. The drug accounts for the entire market value of Resverlogix.

The drug met the main goal of a mid-stage trial of significantly increasing HDL-C (HDL), or "good" cholesterol levels, in August.

Calgary, Alberta-based Resverlogix said the new company's shares will not be listed initially.

(Reporting by Krithika Krishnamurthy in Bangalore)

Comments